Gallagher Neil

Former Director at ZYME; Officer at SNDX

Sold, on record
$72k
Dollars the filings state
Form 4 sales
1
Latest Feb 10, 2025
Form 144 notices
3
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • ZYMEZymeworks Inc.Former Director
  • SNDXSyndax Pharmaceuticals IncOfficer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice SNDXNotice
    Feb 10, 2025 2025

    Filed to sell 4,618 shares ($72k)

    Gallagher Neil, Officer

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale SNDXNo plan
    Feb 10, 2025 same day

    Sold 4,618 shares at $15.50 ($72k)

    Gallagher Neil, President, Head of R&D

    No 10b5-1 planSold 5.1% of holdings ($1.4M position)85,095 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice SNDXNotice
    Jul 10, 2025 +150 days

    Filed to sell 9,679 shares ($90k)

    Gallagher Neil, Officer

    No 10b5-1 planFiling

  4. 4 Form 144 notice ZYMENotice
    Nov 21, 2025 +134 days

    Filed to sell 105,000 shares ($2.5M)

    Gallagher Neil, Former Director

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Gallagher Neil
Source
Nov 21, 2025Nov 21, 2025ZYMEFormer DirectorForm 144 notice105,000$2.5MNoticeSEC
Jul 10, 2025Jul 10, 2025SNDXOfficerForm 144 notice9,679$90kNoticeSEC
Feb 10, 2025Feb 12, 2025SNDXPresident, Head of R&DForm 4 sale4,618$72k5.1%No planSEC
Feb 10, 2025Feb 10, 2025SNDXOfficerForm 144 notice4,618$72kNoticeSEC